Comprehensive Analysis of HGH Fragment (176-191)
HGH Fragment (176-191) is a synthetic peptide derivative representing the C-terminal portion of human growth hormone, specifically encompassing amino acids 176 through 191. This research compound maintains the lipolytic properties of the parent hormone while eliminating the growth-promoting effects, making it valuable for investigating selective metabolic pathways in laboratory settings. Researchers studying metabolic regulation can examine this fragment’s interaction with fat cell receptors and its influence on lipolysis mechanisms. The peptide’s unique structure allows for focused investigation into adipose tissue metabolism without the confounding variables associated with full-length growth hormone.
Laboratory Research Applications
Investigators utilise HGH Fragment (176-191) to study cellular energy metabolism, particularly in adipocyte cultures and metabolic pathway research. The compound enables researchers to evaluate lipolytic enzyme activation, examine fatty acid mobilisation mechanisms, and analyse metabolic signalling cascades in controlled laboratory environments. Scientists investigating obesity-related pathways find this fragment particularly useful for studying selective receptor binding without growth hormone’s anabolic effects. Research institutions examining metabolic disorders can investigate this peptide’s role in energy homeostasis and fat metabolism regulation. Laboratory studies focus on understanding how this specific amino acid sequence influences cellular metabolism and energy expenditure pathways.
Technical Specifications
| Parameter | Specification |
|---|---|
| Purity | >99% (HPLC verified) |
| Molecular Weight | Verify with supplier |
| Sequence | Human GH amino acids 176-191 |
| Formulation | Lyophilised powder |
| Storage | -20°C, protect from light |
| Solubility | Sterile water, bacteriostatic water |
Quality control testing includes mass spectrometry verification, amino acid composition analysis, and bacterial endotoxin testing. Each vial undergoes rigorous purity assessment to ensure research-grade standards. Storage protocols maintain peptide stability and prevent degradation during extended research periods.
Regulatory Compliance and Research Use
This product is manufactured exclusively for in-vitro research applications and laboratory investigation purposes. HGH Fragment (176-191) is not approved for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must maintain appropriate laboratory safety protocols when handling this compound. All studies should follow institutional guidelines for peptide research and disposal procedures. This compound is available to qualified research institutions and licensed laboratories for legitimate scientific investigation only. Investigators can explore comprehensive research compounds at Stroid UK Shop, examine additional HGH fragment research tools, review selective receptor modulators, or investigate other research peptides for comparative studies.
